AARDVARK THERAPEUTICS INC (AARD) Forecast, Price Target & Analyst Ratings

NASDAQ:AARD • US0029421007

Current stock price

4.225 USD
+0.13 (+3.3%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AARDVARK THERAPEUTICS INC (AARD).

Forecast Snapshot

Consensus Price Target

Price Target
$18.77
+ 344.21% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.86
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
87.78%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$18.77
Upside
+ 344.21%
From current price of $4.23 to mean target of $18.77, Based on 18 analyst forecasts
Low
$6.06
Median
$15.30
High
$47.25

Price Target Revisions

1 Month
-43.62%
3 Months
-43.29%

Price Target Summary

18 Wall Street analysts provided a forecast for the next 12 months for AARD. The average price target is 18.77 USD. This implies a price increase of 344.21% is expected in the next year compared to the current price of 4.225.
The average price target has been revised downward by 43.29% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

AARD Current Analyst RatingAARD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

AARD Historical Analyst RatingsAARD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
87.78%
AARD was analyzed by 18 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about AARD.
In the previous month the buy percentage consensus was at a similar level.
AARD was analyzed by 18 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-24BTIGReiterate Buy -> Buy
2026-03-02BTIGMaintains Buy -> Buy
2026-03-02OppenheimerMaintains Outperform -> Outperform
2026-03-02RBC CapitalDowngrade Outperform -> Sector Perform
2026-03-02StifelDowngrade Buy -> Hold
2026-03-02Morgan StanleyDowngrade Overweight -> Equal-Weight
2026-03-02HC Wainwright & Co.Downgrade Buy -> Neutral
2026-02-10BTIGReiterate Buy -> Buy
2026-02-09HC Wainwright & Co.Reiterate Buy -> Buy
2025-12-23OppenheimerInitiate Outperform
2025-12-12William BlairInitiate Outperform
2025-11-14RBC CapitalMaintains Outperform -> Outperform
2025-11-07BTIGInitiate Buy
2025-10-01Jones TradingInitiate Buy
2025-09-29StifelInitiate Buy
2025-09-23HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-28B of A SecuritiesMaintains Buy -> Buy
2025-08-14RBC CapitalMaintains Outperform -> Outperform
2025-06-30HC Wainwright & Co.Initiate Buy
2025-05-15RBC CapitalMaintains Outperform -> Outperform
2025-04-01Cantor FitzgeraldReiterate Overweight -> Overweight
2025-04-01RBC CapitalReiterate Outperform -> Outperform
2025-03-27B of A SecuritiesMaintains Buy -> Buy
2025-03-10Cantor FitzgeraldInitiate Overweight
2025-03-10RBC CapitalInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.86
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-21.47%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.33%
EPS (3 Months)
0.63%

Next Earnings Summary

AARD is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.86 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
AARD revenue by date.AARD revenue by date.
N/AN/A
2,107.17%		N/A
975.05%		N/A
258.87%		N/A
29.49%		N/A
55.76%		N/A
39.18%		N/A
22.73%
EBITDA
YoY % growth
AARD ebitda by date.AARD ebitda by date.
-10.253M-7.318M
28.63%		-22.769M
-211.14%		-62.689M
-175.33%		N/A
-21.15%		N/A
-12.02%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
AARD ebit by date.AARD ebit by date.
-10.363M-7.415M
28.45%		-22.785M
-207.28%		-62.725M
-175.29%		N/A
-39.43%		N/A
-29.22%		N/A
11.78%		N/A
64.34%		N/A
256.06%		N/A
188.43%		N/A
72.70%		N/A
56.21%
Operating Margin
AARD operating margin by date.AARD operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
AARD eps by date.AARD eps by date.
N/AN/AN/A-2.93N/A
-34.03%		N/A
-2.10%		N/A
44.03%		N/A
279.09%		N/A
-19.12%		N/A
41.00%		N/A
57.27%		N/A
35.66%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.86
-21.47%		-0.94
-41.67%		-0.93
-24.21%		-1.00
-22.85%		-1.24
-44.28%		-1.53
-63.64%		-1.95
-109.12%		-2.37
-137.81%		-2.76
-122.13%		-2.25
-47.33%		-1.51
22.51%		-0.89
62.50%
Revenue
Q2Q % growth		N/AN/AN/AN/AN/A17.167M40.045M59.66M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-19.254M
-83.89%		-21.266M
-34.19%		-22.132M
-25.02%		-23.988M
-28.25%		N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AARD Yearly Revenue VS EstimatesAARD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
AARD Yearly EPS VS EstimatesAARD Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
7.26%
EPS Next 5 Year
25.47%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AARDVARK THERAPEUTICS INC / AARD Forecast FAQ

What is the price target for AARD stock?

18 analysts have analysed AARD and the average price target is 18.77 USD. This implies a price increase of 344.21% is expected in the next year compared to the current price of 4.225.

Can you provide the upcoming earnings date for AARDVARK THERAPEUTICS INC?

AARDVARK THERAPEUTICS INC (AARD) will report earnings on 2026-05-12.

Can you provide the consensus estimates for AARDVARK THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of AARDVARK THERAPEUTICS INC (AARD) is -0.86 USD and the consensus revenue estimate is 0 USD.